BCART — Biocartis NV Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
Brief: Biocartis Announces Change In Board Composition
Brief: Biocartis Group Announces Launch Of First Assay Developed With New Idylla™ Flex Technology
Brief: Biocartis FY22 Operating Cash Burn At EUR 38.5 Mln
Brief: Biocartis Group Announces Completion Of Recapitalization Transactions
Brief: Biocartis/Convertible Bonds Due 2027: Completion Of Mandatory Conversion
Brief: Biocartis: Increase In Share Capital After Successful Capital Increase
Brief: Biocartis Group Announces Successful Rights Offering
Brief: Biocartis Starts Scrips Sale Through Private Placement
Brief: Biocartis Launches Rights Offering Of Maximum Of 33.5 Million Offered Shares
Brief: Biocartis: New Idylla EGFR Study Shows Reduction Of Time-To-Treatment For Lung Cancer Patients
Brief: Biocartis: Conversion Of Portion Of Loan Into New Shares
Brief: Biocartis Group Raises FY Guidance for Product Gross Margin
Brief: Biocartis Group Announces First Drawdown Of New Convertible Term Loans
Brief: Biocartis Group Announces Amendment Of Its Existing Convertible Bonds
Brief: Biocartis Initiates Commercialization In Europe Of Hepatopredict Test For Liver Cancer Patients
Brief: Biocartis: Launch Of Amendment Process And Exchange Offer For Existing Convertible Bonds
Brief: Biocartis Starts Commercialization In Europe Of Merlin Assay
Brief: Biocartis Obtains Iso 27001 Certification For Information Security Management
Brief: Biocartis Expands Collaboration Agreement With AstraZeneca